The Incidence and Utilization Pattern of Antituberculosis (TB) Drugs in Chronic Dialysis Patients in Taiwan

The Incidence and Utilization Pattern of Antituberculosis (TB) Drugs in Chronic Dialysis Patients in Taiwan

碩士 === 國立成功大學 === 臨床藥學與藥物科技研究所 === 103

Bibliographic Details
Main Authors:	Yi-CheHuang, 黃詣喆
Other Authors:	Yea-Huei Kao Yang
Format:	Others
Language:	zh-TW
Published:	2015
Online Access:	http://ndltd.ncl.edu.tw/handle/01046002292316991548

Similar Items

THE INCIDENCE OF MYCOBACTERIUM TUBERCULOSIS INFECTIONS AND RESISTANCE TO ANTITUBERCULOSIS DRUGS IN GIURGIU POPULATION
by: Ionica Deliu, et al.
Published: (2014-11-01)

Over the Counter Availability of Antituberculosis Drugs in Tbilisi, Georgia in the Setting of a High Prevalence of MDR-TB
by: Ketevan Kobaidze, et al.
Published: (2009-01-01)

Role of Quantiferon TB gold assays in monitoring the efficacy of antituberculosis therapy
by: N. Helmy, et al.
Published: (2012-10-01)

Incidence and characteristics of antituberculosis drug-induced hepatotoxicity in children: a preliminary study
by: Bina Akura, et al.
Published: (2009-12-01)

Acquired Resistance to Antituberculosis Drugs
by: Htin Lin Aung, et al.
Published: (2018-11-01)

Definition of drug resistance of Mycobacterium tuberculosis to antituberculosis drugs in patients with multidrugresistant tuberculosis and TB with extremely drug resistant depending on the case of the disease
by: Kryzhanovsky D.G., et al.
Published: (2014-11-01)

Antituberculosis drug-induced hepatotoxicity in children
by: Peter R. Donald
Published: (2011-06-01)

Effective interventions and decline of antituberculosis drug resistance in Eastern Taiwan, 2004-2008.
by: Yi-Ting Chen, et al.
Published: (2012-01-01)

Efficacy of antituberculosis therapy in combination with antiretroviral therapy in patients with co-infection TB/HIV
by: Kryzhanovsky D.G., et al.
Published: (2013-03-01)

Prescription pattern of antihypertensive agents in incident dialysis patients in Taiwan
by: Chien-HaoSu, et al.
Published: (2011)

Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
by: Oymak Sema F, et al.
Published: (2002-12-01)

Resistance pattern of <em>Mycobacterium tuberculosis</em> to first-line antituberculosis drugs
by: Tjahjani M. Sudiro, et al.
Published: (2000-07-01)

Antituberculosis Drug-induced Hepatotoxicity in Pediatric Tuberculosis
by: Vycke Yunivita, et al.
Published: (2019-10-01)

Mycobacterium tuberculosis resistance to antituberculosis drugs in Mozambique
by: Germano Manuel Pires, et al.
Published: (2014-04-01)

Resistance to first- and second-line antituberculosis drugs in Southern Taiwan: Implications for empirical treatment
by: Cheng-Yu Kuo, et al.
Published: (2018-02-01)

Drug–drug interaction analysis: Antituberculosis drugs versus antiretroviral drugs
by: Won Sriwijitalai, et al.
Published: (2019-01-01)

Pattern of drug resistance of Mycobacterium tuberculosis clinical isolates to first-line antituberculosis drugs in pulmonary cases
by: Deepika Kalo, et al.
Published: (2015-01-01)

Benefits of Therapeutic Drug Monitoring of First Line Antituberculosis Drugs
by: Prso K, et al.
Published: (2020-08-01)

Analysis on the clinical characters of optic neuritis caused by antituberculosis drugs
by: Yi-Luan Jian, et al.
Published: (2014-09-01)

Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients
by: Raquel Lima de Figueiredo Teixeira, et al.
Published: (2011-09-01)

Repurposing chlorpromazine and its metabolites for antituberculosis drug discovery
by: Kigondu, Elizabeth Victoria Mumbi
Published: (2016)

Aureolic Acid Group of Agents as Potential Antituberculosis Drugs
by: Julia Bespyatykh, et al.
Published: (2020-10-01)

Seizures following Intoxication with a Common Antituberculosis Drug
by: Adnane Lahlou, et al.
Published: (2019-01-01)

Combined antiretroviral and antituberculosis drug resistance following incarceration
by: Katharine Elizabeth Stott, et al.
Published: (2013-09-01)

Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis Patients
by: Aliasghar Farazi, et al.
Published: (2014-01-01)

Risk factors associated with adverse reactions to antituberculosis drugs
by: Laíse Soares Oliveira Resende, et al.
Published: (2015-02-01)

Correlation of antituberculosis drug-related liver injury and liver function monitoring: A 12-year experience of the Taiwan Drug Relief Foundation
by: Lan-Hui Chih, et al.
Published: (2014-09-01)

Antituberculosis treatment and hepatotoxicity in patients with chronic viral hepatitis
by: Yuan-Meng Liu, et al.
Published: (2013)

An Analysis of Medical Utilization and Mortality Rate of Chronic Dialysis Patients in Taiwan
by: Hsiu-Li Lei, et al.
Published: (2001)

Hepatitis B and C Virus Carriers Increase Risk for Active TB Patients with Hepatotoxicity by Taking the First-line Antituberculosis Drug: A Meta-analysis
by: Ying-An Chen, et al.
Published: (2007)

Developing Corporate Social Responsibility Strategies for Taiwan International Ports Corporation
by: Chen-CheHuang, et al.
Published: (2016)

The Impact of Smoking on the Antituberculosis Therapy
by: Yi-Chun Chiang, et al.
Published: (2005)

Clinical deterioration during antituberculosis treatment in Africa: Incidence, causes and risk factors
by: Bhaijee Feriyl, et al.
Published: (2010-03-01)

Preclinical pharmacokinetic evaluation of novel antimalarial and antituberculosis drug leads
by: Strydom, Natasha
Published: (2019)

New antituberculosis drugs: from clinical trial to programmatic use
by: Gina Gualano, et al.
Published: (2016-06-01)

Adverse reaction to antituberculosis drugs (ADRA). A reality in Bolivia
by: Mamani-Poma Augusto
Published: (2018-02-01)

Antituberculosis drugs and hepatotoxicity among hospitalized patients in Jos, Nigeria
by: Samson E Isa, et al.
Published: (2016-01-01)

Correlation between Antituberculosis Drug-Induced Hepatotoxicity and Patient’s Diseases
by: Yung-Chia Hsu, et al.
Published: (2010)

Patients Using Antituberculosis Drugs with Medications for Their Comorbidity to Cause Hepatotoxicity
by: Tzu-I Tang, et al.
Published: (2013)

PRECLINICAL STUDIES OF THE SPECIFIC ACTIVITY OF THE NEW ANTITUBERCULOSIS DRUG THIOZONIDE
by: I. V. Bocharova, et al.
Published: (2014-06-01)

Cannot write session to /tmp/vufind_sessions/sess_km2b12i2h5cctgq7b1tp7i4k73